Rocket Pharmaceuticals: Multiple Regulatory Submissions Make It A Must Watch (RCKT)

Microscopic blue bacteria background

fatido/E+ via Getty Images

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is an ideal biotech to keep an eye on this year. That’s because it has made advancements on several fronts in terms of possible regulatory approvals for its gene therapies. In

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *